Amar Jesani | Indian Journal of Medical Ethics | Vol 10, No 2 | Apr-Jun 2013 In 2005, the government amended Schedule Y of the Drugs and Cosmetics Act, 1940, and Rules, 1945, to liberalise the conduct of global drug trials… Continue reading
Amar Jesani | Indian Journal of Medical Ethics | Vol 10 No 2 | 2013 In 2005, the government amended Schedule Y of the Drugs and Cosmetics Act, 1940, and Rules, 1945, to liberalise the conduct of global drug trials… Continue reading
Vikas Bajpai | Centre for Social Medicine and Community Health, Jawaharlal Nehru University | ISRN Public Health Volume 2013 (2013) Clinical trials industry has seen a phenomenal increase in last ten years or so, and India has emerged as one of… Continue reading
A. Raju | PharmaBiz.com | Hyderabad | 4 May 2013 The clinical trial industry in India is currently facing a challenging time and witnessing a downward trend as investors are looking to shift their focus to other liberal destinations like… Continue reading
The New Indian Express | PTI – New Delhi | 21 April 2013 Clinical trials of drugs in India have seen a drastic fall this year after toughened norms were introduced following Supreme Court directives. Not only have the number of… Continue reading
Renuka Munshi, Urmila Thatte | Perspectives in Clinical Research | v.4(1) | Jan-Mar 2013 | Source: NCBI-PMC In March 2006, eight healthy volunteers in a phase I trial received a T cell agonist at Parexel’s clinical pharmacology research unit at… Continue reading
